# EDGAR Filing Document

**Accession Number:** 0001527762
**File Stem:** 0000000000-25-005817
**Filing Date:** 2025-6
**Character Count:** 8451
**Document Hash:** de0971ef451332f942c2cb02dfdb30a0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-005817.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0000000000-25-005817

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250603

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Mercurity Fintech Holding Inc.
- **CENTRAL INDEX KEY:** 0001527762
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **ORGANIZATION NAME:** 09 Crypto Assets
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-287428

**BUSINESS ADDRESS:**
- **STREET 1:** 1330 AVENUE OF THE AMERICAS, FL 33,
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** (8610) 6266 8858

**MAIL ADDRESS:**
- **STREET 1:** 1330 AVENUE OF THE AMERICAS, FL 33,
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JMU Ltd
- **DATE OF NAME CHANGE:** 20161230

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Wowo Ltd
- **DATE OF NAME CHANGE:** 20110810
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001641172-25-011703

## Text-Extract

```

                                                            June 3, 2025

Shi Qiu
Chief Executive Officer
Mercurity Fintech Holding Inc.
1330 Avenue of the Americas, Fl 33
New York, NY 10019

       Re: Mercurity Fintech Holding Inc.
           Registration Statement on Form F-3
           Filed May 20, 2025
           File No. 333-287428
Dear Shi Qiu:

       We have conducted a limited review of your registration statement and
have the
following comments.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments.

Registration Statement on Form F-3
General

1.     Please include a prospectus summary heading pursuant to Item 3 of Form
F-3. In the
       prospectus summary, please also address the following:
           Disclose each permission or approval that you or your subsidiaries
are required to
           obtain from Chinese authorities to operate your business and to
offer the securities
           being registered to foreign investors. State whether you or your
subsidiaries are
           covered by permissions requirements from the China Securities
Regulatory
           Commission (CSRC), Cyberspace Administration of China (CAC) or any
other
           governmental agency that is required to approve your company's
operations, and
           state affirmatively whether you have received all requisite
permissions or
           approvals and whether any permissions or approvals have been denied.
Please
           also describe the consequences to you and your investors if you or
your
 June 3, 2025
Page 2

           subsidiaries: (i) do not receive or maintain such permissions or
approvals, (ii)
           inadvertently conclude that such permissions or approvals are not
required, or (iii)
           applicable laws, regulations, or interpretations change and you are
required to
           obtain such permissions or approvals in the future.
             Provide a clear description of how cash is transferred through
your organization.
           Disclose your intentions to distribute earnings or settle amounts
owed under your
           operating structure. Quantify any cash flows and transfers of other
assets by type
           that have occurred between the holding company and its subsidiaries,
and
           direction of transfer. Quantify any dividends or distributions that
a subsidiary has
           made to the holding company and which entity made such transfer, and
their tax
           consequences. Similarly quantify dividends or distributions made to
U.S.
           investors, the source, and their tax consequences. Please also
disclose whether
           you have cash management policies that dictate how and when funds
are
           transferred or distributed. Your disclosure should make clear if no
transfers,
           dividends, or distributions have been made to date. Describe any
restrictions on
           foreign exchange and your ability to transfer cash between entities,
across
           borders, and to U.S. investors. Describe any restrictions and
limitations on your
           ability to distribute earnings from the company, including your
subsidiaries, to the
           parent company and U.S. investors as well as the ability to settle
amounts owed
           under applicable agreements. If no difficulties are identified, then
state that there
           is no assurance that the PRC government will not intervene or impose
restrictions
           on your company   s ability to transfer cash into or out of China
and/or Hong
           Kong.
Cover Page

2.     Provide a description of how cash is transferred through your
organization and
       disclose your intentions to distribute earnings or settle amounts owed
under applicable
       agreements. State whether any transfers, dividends, or distributions
have been made to
       date between the holding company and its subsidiaries, or to investors,
and quantify
       the amounts where applicable. In addition, provide cross-references to
the
       consolidated financial statements in your Form 20-F filed April 30,
2025.
3.     We note your disclosure on the cover page that "[t]o a certain extent,
we are subject to
       legal and operational risks associated with having part of our
operations, in mainland
       China, including risks related to the legal, political and economic
policies of the
       Chinese government, the relations between China and the United States,
and changes
       in Chinese laws and regulations." Please revise to remove the words
"[t]o a certain
       extent."
Summary of Risk Factors
Risks Relating to Doing Business in the PRC, page 6

4.     In this section, disclose in more detail the risks that your corporate
structure and
       having the company   s operations in China and Hong Kong poses to
investors, with
       cross-references to the more detailed discussion of these risks in your
Form 20-F filed
       April 30, 2025. For example, specifically discuss the risk that the
Chinese government
       may intervene or influence your operations at any time, which could
result in a
 June 3, 2025
Page 3

       material change in your operations and/or the value of the securities
you are
       registering for sale. Acknowledge any risks that any actions by the
Chinese
       government to exert more oversight and control over offerings that are
conducted
       overseas and/or foreign investment in China-based issuers could
significantly limit or
       completely hinder your ability to offer or continue to offer securities
to investors and
       cause the value of such securities to significantly decline or be
worthless.
Enforceability of Civil Liabilities, page 27

5.     We note that your enforceability of civil liabilities discussion
addressing the
       enforceability of civil liabilities in Hong Kong. Please revise to
disclose how you
       arrived at your conclusions with respect to such discussion. To the
extent that you
       relied on an opinion of counsel, please identify counsel and include
counsel's consent
       as an exhibit.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

       Please contact Irene Paik at 202-551-6553 or Sonia Bednarowski at
202-551-3666
with any questions.

                                                             Sincerely,

                                                             Division of
Corporation Finance
                                                             Office of Crypto
Assets
cc:   Huan Lou, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._